Search for: "MAJOR PHARMACEUTICALS"
Results 121 - 140
of 4,361
Sort by Relevance
|
Sort by Date
9 Nov 2023, 7:12 pm
The required notice period may be reduced if agreed between the employer and a majority of the relevant employees. [read post]
9 Nov 2023, 5:00 am
Under-investment in social determinants of health are major drivers of inequitable health outcomes in the United States. [read post]
3 Nov 2023, 3:04 pm
On October 30, the Department of Justice announced that the pharmaceutical manufacturer Nostrum Laboratories, Inc., had agreed to pay at least $50 million to settle civil allegations that the company defrauded the Medicaid program by failing to pay rebates. [read post]
2 Nov 2023, 8:12 am
David has represented whistleblowers and governments in major false claims act cases. [read post]
2 Nov 2023, 4:56 am
The vast majority of our patent licensing agreements are agreed amicably. [read post]
24 Oct 2023, 9:50 am
Pix Credit Charlie Chaplin, "Modern Times" If you’ve been paying attention to the policies we’ve implemented over the past two years, you’ve probably noticed that I talk a lot about empowering general counsels and compliance officers – to make the case in the board room and the c-suite for investments in compliance – and to make the case that investing in strong compliance programs is good for business. [read post]
20 Oct 2023, 8:19 am
Antitrust Matters provides engaging and timely conversations about competition policy in the digital age. [read post]
18 Oct 2023, 12:52 pm
The FTC focuses on insurance, pharmaceuticals, and consumer protection issues. [read post]
18 Oct 2023, 10:26 am
The major problem with the Texas and Florida transparency laws is that they will powerfully incentivize platforms to change their editorial rules for online speech. [read post]
17 Oct 2023, 3:40 pm
In particular, the PRJ considered that it is not necessary for the patentee to provide proof, or make it plausible in summary proceedings, that the technical effect works with at least the majority of the claimed compositions. [read post]
10 Oct 2023, 4:00 am
The Food and Drug Administration recently updated the warning label on Horizon Pharmaceutical’s TEPEZZA. [read post]
9 Oct 2023, 9:01 pm
The SEC charged six officers, directors, and major shareholders of public companies and five public companies for failing to file Forms 4 and Schedules 13D and 13G on a timely basis. [read post]
5 Oct 2023, 9:01 pm
In fact, already this year, the number of major national-security corporate resolutions has doubled compared to last year. [read post]
3 Oct 2023, 6:30 am
As the Constitutional Court recognized in its important Pharmaceutical Manufacturers judgment, “Courts no longer have to claim space and push boundaries to find means of controlling public power. [read post]
2 Oct 2023, 11:42 pm
Particularly, understanding a mechanical invention generally does not require the complexity of data interpretation needed in the biotech and pharmaceutical field. [read post]
30 Sep 2023, 12:24 pm
Court of Appeals for the Sixth Circuit stayed a preliminary injunction against a Tennessee law barring pharmaceutical and surgical gender-affirming care for minors diagnosed with gender dysphoria. [read post]
28 Sep 2023, 8:08 am
The County, State, utilities and landowners were given an astounding five years to prepare between major fires in Lahaina, but did nothing. [read post]
27 Sep 2023, 7:15 pm
In all, according to our estimates, 75 percent of the benefits of striking down the MRT would go to just three sectors: tech, pharmaceuticals, and finance. [read post]
25 Sep 2023, 7:00 am
Within healthcare, Bain Capital targets companies in the provider services, hospital/major facilities, life sciences/pharmaceutical and non-reimbursement industries. [read post]
22 Sep 2023, 4:00 am
Louis Milione retired from the DEA a second time this summer amid reporting on potential conflicts caused by his prior consulting for the pharmaceutical industry. [read post]
